chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Less than 5 minutes after receiving the vaccine, I experienced tingling in my left fingers. Less than 15 minutes of receiving the Covid-19 Pfizer vaccine, I experienced chest tightness and shortness of breath.  I thought I was having an asthma attack, so I proceeded to use my inhaler. After using the inhaler, I started coughing while trying to breathe.  Next my tongue started swelling, followed by my throat and back of the tongue.  The nurses / EMT reported that my face turned red and my heart-rate was elevated.  The EMT proceeded to give me EpiPen, which almost instantly caused the swelling in my tongue to go down.  While being monitored for 3 more hours at the emergency room, the swelling went down even more and breathing became more normal.  The following day, I visited my allergist doctor, and I was still experiencing some swelling in my neck and chest tightness.  I was given a steroid shot, which seemed to clear the rest of the allergic reaction.
hands were shaking; cold; headache in my right temple and right base of head which lasted most of thetime all of this was going o; then started heating up. Ears first then whole body. My temperature was over 100 degrees, no sweating but felt like I was burning up.; This is a spontaneous report from a contactable consumer, the patient. A 66-years-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW-0150) via an unspecified route of administration in the left arm on 03Apr2021 at 11:00 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included Hashimoto's disease and Raynaud's. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), vitamin B (MANUFACTURER UNKNOWN), cholecalciferol (vitamin D3) (MANUFACTURER UNKNOWN), fish oil (MANUFACTURER UNKNOWN) and curcuma longa (turmeric curcu) (MANUFACTURER UNKNOWN). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN-6208) via an unspecified route of administration in the left arm on 15Mar2021 at 11:00 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. On 03Apr2021 at 21:30, the patient experienced whole body was cold and hands were shaking. The patient never felt this type of freezing cold ever. Also, had a headache in right temple and right base of head which lasted most of the time, all of this was going on. The patient then started heating up. Ears first then whole body. The temperature was over 100 degrees, no sweating but felt like she was burning up. It would let up a little for about a half-hour at a time but start again. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events, cold and hands were shaking, headache in right temple and right base of head and temperature was over 100 degrees was resolved in Apr2021.   No follow-up attempts are needed. No further information is expected.
Acute on chronic respiratory failure with hypoxia - The patient was admitted and was thought to most likely have evidence of hospital-acquired pneumonia.  The patient was continued on Zosyn and vancomycin.  Vancomycin was discontinued after MRSA testing was negative.  Patient continued to have significant improvement in her symptoms. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
Patient  developed an itchy rash on torso and upper body. They were red almost like pimples and very itchy. Also developed a fever of 102, and arm was throbbing.  Father alternated Ibuprofen and Tylenol for the fever , and Benadryl for the itchy rash. Today she is doing much better but still has a itchy rash on the arm. She no longer has a fever and seems to be much better.
Densely spaced erythematous pinpoint papules and macules ant, L lat, and R lat neck and upper chest. Otherwise well.
Patient is currently pregnant; EDD: 5-3-19. Was seen on 3-7-19 for OB visit, was 31.6 weeks on this day and due to Tdap. Inadvertently given a FLUBLOK injection. Patient had apparently already received flu shot at another location in November. We have no record of this flu vaccine and no information in records. Location where shot given in November is apparently now closed. Medical Director notified as well as CNM and contacted Maternal Fetal Specialist who informed us he knew of no adverse reactions from patient receiving a second flu vaccine. Was subsequently seen again for OB FU on 3/18/19 and reported no adverse reactions to CNM.
Received injection approx. 4PM, 11-10-05.  Became suddenly hoarse followed by a raspy cough at approx. 8PM.  Cough continued despite fluids, food, cough drop.  At 10PM, "remembered" I had had the flu shot...checked sheet issued to me and noted severe reactions listed.  By 11PM, upper chest area seemed a bit heavy when breathing but did not have shortness of breath.  Cough was subsiding by midnight but noted tachycardia while at rest...125-130/minute.  Nose and nasopharynx became congested and was unable to "nose breathe".  Fell asleep only to be awakened at 2AM with severe shaking chill...did not take temp.  Once calmed down, I went back to sleep.  Awakened again about 3AM with another chill but was less intense than earlier.  Was able to breathe some through nasal passages.  By 7AM, I only had a slight frontal headache and the tachycardia plus all other symptoms were absent.  No further problems.  Some soreness and bruising at injection site but no rash, etc.  Took no medications for any of the above listed items.
Patient presented to primary care clinic for routine appointment on 11/13/19 in the morning, given 2 vaccines as part of health maintenance.  Presented to same facility's ER on 11/14/19 mid-day reporting symptoms that started approximately 1700 the day prior (later on the same day as the vaccines were given).  Symptoms reported include headache, nausea, chills, body aches.  Took OTC Goody powder without relief.  Denied dizziness, vomiting, paralysis, rhinitis, sneezing, cough, chest pain, shortness of breath, sore throat, chest/nasal congestion.  Denied travel or ill contacts.  Good oral intake and appetite maintained.  No medications given in the ER, discharged with ondansetron as needed for nausea and acetaminophen as needed for pain/headache as well as instructed to rest and drink plenty of fluids.
Patient was given a pediatric dose of Hep A vs. the adult dose of Hep A.
When I received the 2nd dose of the vaccine, I was 26 weeks and 3 days pregnant. My estimated due date is 07/10/2021. I received the vaccine mid-morning on 4-6-2021. The following day (4-7-2021), I experienced arm soreness, fatigue, muscle aches, and chills. Those symptoms were subsiding by the evening of 4-7-2021. Early in the morning of 4-8-2021, I was wakened from sleep because my heart felt like it was beating too fast and too hard. This experience was most intense when lying on my left side, and at its most intense, I felt like I couldn't quite catch my breath. Sitting upright seemed to slow my heart rate. Walking caused it to increase again, and I felt more winded than usual walking short distances. I contacted my OB-GYN when her office opened on 4-8-2021 and told her what I'd been experiencing, and she instructed me to go to the hospital to be evaluated. I was admitted and monitored in Labor and Delivery continuously all day. My heart rate was elevated. My fetus's heart rate was normal. I had an EKG which was normal. I had labs done (CBC, metabolic, thyroid, progesterone), and all were normal. I was not found to be dehydrated, but I was given a liter of fluids IV as a precaution. Over the course of the day, my heart rate returned to normal, and I was discharged.
Shoulder & neck pain on left side (the side the shot was given).  Seven days later I still have pain.  Advil takes the edge off the pain as well as heat.
did not feel well; Coughing; shortness of breath; Asthma has been acting up and feeling "under the weather", Asthma lately getting worse; pain during injection and flare-ups; Initial information received on 26-Nov-2019 regarding an unsolicited valid non-serious case received from a consumer.  This case involves a 48 years old female patient (162.56 cm and 68.027 kg) who experienced asthma has been acting up and feeling "under the weather", asthma lately getting worse, did not feel well, coughing, shortness of breath and pain during injection and flare-ups, while she received vaccine INFLUENZA VACCINE and while treated with DUPILUMAB [DUPIXENT].  The patient's past medical history included Allergic rhinitis, sinusitis and PE in lungs. The patient's past medical treatment(s), vaccination(s) and family history were not provided. At the time of the event, the patient had ongoing Asthma.  Concomitant medications included SALBUTAMOL SULFATE (PROAIR) and FLUTICASONE FUROATE, VILANTEROL TRIFENATATE (BREO ELLIPTA).  In Aug-2019, the patient started taking DUPIXENT (DUPILUMAB) 300 mg every two weeks under the skin (with an unknown batch number, 31-Dec-2021) for Dermatitis atopic.  On 31-Oct-2019, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient's asthma has been acting up and feeling "under the weather", asthma lately getting worse (asthma), did not feel well (malaise), coughing (cough), shortness of breath (dyspnoea) and pain during injection and flare-ups (injection site pain) (unknown latency) following the administration of INFLUENZA VACCINE and DUPILUMAB.  Other relevant tests not reported.  Final diagnosis was asthma, malaise, cough, dyspnoea and injection site pain.  Action taken with DUPILUMAB (DUPIXENT) was unknown.  It was not reported if the patient received a corrective treatment.  The outcome was unknown for all the events.  Information on the batch number was requested.
Sore arm, headache , fever 102, stomach pain , chills shivering. O2 was156/95
she tested positive for Covid; she tested positive for Covid; This is a spontaneous report from a contactable consumer (patient) reported a female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 25Feb2021 as single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced she tested positive for covid on 01Mar2021. The report received as the patient received her first shot of the vaccine on 25Feb2021. And four days later, she tested positive for Covid. She is due to take his second dose this Thursday. She wanted to confirm if she can take the vaccine or not. The patient underwent lab tests and procedures which included covid-19: positive on 01Mar2021. The events were assessed as medically significant. Outcome of the event was unknown.   Information on the lot/batch number has been requested.
Patient is fully vaccinated.  COVID positive on 12/30=1/2021 at  ED visit. Chief complaint, headache. 20-year-old female presents to the ED due to headache ongoing for the past 2-3 days but worsening today. Patient states headache starts in the occipital region radiating to the front, described as dull and achy but no change in vision. Patient has history of headaches and migraines but states this seems to be slightly different. Patient at this time denies any chest pain, shortness breath, fever, chills, nausea, vomiting, diarrhea, constipation, urinary symptoms or any abdominal pain. Patient though does states has some sinus tenderness. Positive for photophobia.BP 161/74  | Pulse 98  | Temp 98.4 °F (36.9 °C) (Oral)  | Resp 16  | Ht 160 cm (5' 3")  | Wt 103 kg (227 lb)  | LMP 12/02/2021  | SpO2 99%  | BMI 40.21 kg/m² CT head: no acute intracranial abnormality.Patient given migraine cocktail and Xanax for anxiety, given steroids while in the ED, to follow up with PCP and given resources for monoclonal antibody therapy. Discharged home.
9/4/14 - Chills at night. 9/5/14 at 11:00 - pain, redness, and swelling, decreased ROM - tried ice, BENADRYL and ALLEVE - no relief. 9/6/14 at 11:00 - started BACTRIM DS  by doctor. Dx: Cellulitis. 9/8/14 - painlegs started feeling better, less swelling.
Sore throat, coughing, dizziness, headache, arm at injection fatigued and painful,  crabby, irritable, frustrated and regretful, nasal drippage, sinus pain, sneezing, restless, ear plugging and ear ache
Initial unsolicited report received from a pharmacist on 12-Oct-2016. This case was linked with cases 2016SA189772, 2016SA189781, 2016SA189791, 2016SA189792, 2016SA189793, 2016SA189794, 2016SA189795, 2016SA189796, 2016SA189797, 2016SA189798, 2016SA189799, 2016SA189800, 2016SA189801, 2016SA189802, 2016SA189803, 2016SA189804, 2016SA189805, 2016SA189806, 2016SA189807, 2016SA189808, 2016SA189809, 2016SA189810, 2016SA189812, 2016SA189813, 2016SA189814, 2016SA189815, 2016SA189816, 2016SA189817, 2016SA189818, 2016SA189819, 2016SA189820, 2016SA189821, 2016SA189822, 2016SA189823, 2016SA189824, 2016SA189825, 2016SA189826, 2016SA189827, 2016SA189828, 2016SA189829, 2016SA189830, 2016SA189831, 2016SA189832, 2016SA189833, 2016SA189834, 2016SA189835, 2016SA189836, 2016SA189837, 2016SA189838, 2016SA189839, 2016SA189840, 2016SA189841, 2016SA189842, 2016SA189843, 2016SA189844, 2016SA189845, 2016SA189846, 2016SA189847, 2016SA189848 (Same reporter). This case involves a patient (gender and age not reported) who was vaccinated with a dose of Fluzone Quadrivalent via intramuscular route (Batch number: UI669AA, expiry date: 30-Jun-2017, dose, dose in series and site of administration were not reported) on 04-Oct-2016. Patient's medical history was reported that pre-existing physician diagnosed allergies, birth defects, medical conditions (specify) was unknown. Illness at the time of vaccination was also reported as unknown. Concomitant medications were not reported. Any other vaccinations within four weeks of vaccinations were also not reported. On 06-OCT-2016, two days, following the vaccination, the patient reported Chills, hyperhidrosis and fatigue. Patient required emergency room (ER)/ doctor visit. Laboratory investigations and corrective treatment were not reported. The outcome of event was reported as unknown. List of documents held by sender: none.
I was pretty sick, I felt palsy; I was pretty sick, I felt palsy; I developed the fever for all about 30 hours after the vaccination; Headache; This is a spontaneous report from a contactable physician. This physician reported for himself that a 67-years-old male patient received BNT162B2 (BioNTech Covid 19 vaccine; Batch/lot number: EL1284), via an unspecified route of administration on 30Dec2020 at SINGLE DOSE for "Because I am a physician, a healthcare provider" (covid-19 immunization).  Medical history included had Covid back on the 4th of December.  There were no concomitant medications. Physician stated he was wondering he just took your Pfizer Covid vaccination, the first one. He took it couple of days ago. He took it on the 30th of this month, two days ago. Physician further stated he developed the fever for all about 30 hours after the vaccination. Just because he developed the fever with the first one, it was like a 101.7 that was about 36 hours. So the question was just because he developed the fever with the first one, he was pretty sick, he meant he felt palsy, you know headache and all that it was like probably developed the same with the second one? Patient weight was maybe 125 pounds. When probed if vaccine was prescribed by any Physician, Physician stated he went himself. Causality by physician stated as "he think so". Lab work reported as He did not have the results yet. He just look a Covid screening test because he had Covid back on the 04Dec. So, he just took a Covid screening test. Treatment received included aspirin. The outcome of all events was unknown.; Sender's Comments: The causal relationship between BNT162B2 and the event palsy cannot be excluded as the information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.
Whole-body aches, chills, and tremors (for roughly 30 minutes)
PT WAS GIVEN HIGH DOSE FLUZONE  INSTEAD  OF FLUCEVAX, MANUFACTURE OF VACCINE SANOFI WAS CALLED THEY SHOULD BE NO UNTOWARD EFFECT  SHOULD BE SAME SIDE EFFECT IF GIVEN FLUCELVAX.
Day after receiving shots on 3/24/05 a 50 cent piece size reddened area appeared to LVL warm to touch, still has a marble sized knot today.
Ataxia 1 hour after vaccine, persisted intermittently for 2 weeks. Brief papular rash, intermittent, 1-2 weeks following vaccine.
Pt relays about 15 minutes after receiving the vaccine she began to feel dizzy, near syncope and an upset stomach. Pt relays she believes it is her anxiety. Pt vitals obtained and monitored for another 30 minutes. After 30 minutes Pt relays she is feeling better and feels she can go home. near Syncope, Dizzy, upset Stomach 140/82 100% 90 136/83 100% 84 Pt relays about 15 minutes after recieving the vaccine She began to feel dizzy, near syncope and an upset stomach. Pt relays she believes it is her anxiety. Pt vitals obtained and monitored another 30 minutes. After 30 minutes Pt relays she feels better and feels she can go home.
about 7 weeks after that pneumonia shot that's when that lump started to show up in the arm/taking Braftovi-Mektovi for stage IV melanoma cancer, it started with a lump on his right arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 78-year-old male patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PNEUMOCOCCAL 13-VAL CONJ VAC (DIPHT CRM197 PROTEIN)), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MALIGNANT MELANOMA (medically significant), outcome "unknown", described as "about 7 weeks after that pneumonia shot that's when that lump started to show up in the arm/taking Braftovi-Mektovi for stage IV melanoma cancer, it started with a lump on his right arm". Therapeutic measures were taken as a result of malignant melanoma. Patient's regular doctor told him to get a flu shot, or at least a pneumonia shot. He got it and about 7 weeks after that pneumonia shot that's when that lump started to show up in the arm. Patient is taking Braftovi-Mektovi for stage IV melanoma cancer. He stated that it started with a lump on his right arm, they had him on hemotherapy, immunotherapy, two 2 drugs that they IV (intravenous) in a port on his chest, it was a double dose.   The information on the batch/lot number for pneumococcal 13-val conj vac (dipht crm197 protein), pneumococcal 13-val conj vac (dipht crm197 protein)  has been requested and will be submitted if and when received.
Bruised deltoid muscle, purple in color. It has gotten better in less than 24 hours according to patient.
Patient was given refrigerated Moderna that was expired beyond it's 'Beyond Use Label' date of 01/27/2022.  Vial was placed into fridge on 12/28/2021.  Vial was not removed from fridge in time for 'Beyond Use' expiry date and inadvertently administered.  Manufacturer's expiry date is March 25, 2022.  Provider informed.  Moderna informed and stated that 'the vaccine administered on January 28 to February 7, 2022 from lot number 033H21A maintained the activity necessary to protect against the SARS-CoV-2 (covid 19) virus at time of administration'.   Patient called and informed of adverse event, no adverse effects noted.
NO ADVERSE REACTIONS. DOSE WAS DRAWN FROM A VIAL OPEN THE PREVIOUS DAY 11/18/22 AT 106 PM.
swollen area from elbow to shoulder; appeared like a scald mark; was given APAP prior to inject; given DPH as tx; pt not incapacitated;
This spontaneous report as received from a physician refers to a patient of unknown age. Patient's concurrent or historical conditions were not reported. On 10-DEC-2013 (reported as yesterday by the physician) the patient was vaccinated with ROTATEQ lot # 0210AE, expiration date 29-SEP-2013. Co-suspect or concomitant therapies were not reported. The physician reports that the patient was vaccinated yesterday with ROTATEQ expiration 29-SEP-2013, lot 0210AE. No adverse effect was reported. Additional information has been requested.
Patient stated that she broke out head to toe. The spots were itching and her body got hot. Started in her face and went all over. Patient said that she keeps breaking out.
I went into Afib. I noticed it the first time when I was at the gym on a treadmill. I went to the ER and had an EKG done to determine it was. And now I go to a cardiologist and have a heart monitor.
Injection site nodule; Wrong injection technique; First dose on 1-jan-2021 and second dose on 1-apr-2021; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE NODULE (Injection site nodule), WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Wrong injection technique) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 1-jan-2021 and second dose on 1-apr-2021) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) for Plaque psoriasis.    No Medical History information was reported.   On 01-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced INJECTION SITE NODULE (Injection site nodule), WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Wrong injection technique) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 1-jan-2021 and second dose on 1-apr-2021). At the time of the report, INJECTION SITE NODULE (Injection site nodule), WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Wrong injection technique) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 1-jan-2021 and second dose on 1-apr-2021) outcome was unknown.            There was no reported medical history. The patient took skyrizi shot and it was stuck in leg but able to get medication, this went too far of an angle and pulling at the skin. No concomitant medication were reported. No treatment information were provided. The reporter's causality for the events of SKYRIZI PEN stuck in pen with needle odd angle and developed a knot after SKYRIZI SHOT was not provided.